Experience

Davis Polk advised Vasta Platform Limited in connection with its SEC-registered initial public offering of an aggregate of 18,575,492 Class A common shares, at a price per Class A common…

Davis Polk advised the joint bookrunners in connection with the initial public offering by Grupo de Moda SOMA S.A. and the selling shareholders of 163,636,363 common shares for an…

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 4,000,000 shares of its common stock. The common stock is listed on the…

Davis Polk advised the sole placing agent for the placement of 56,200,000 new shares and 36,800,000 existing shares in Innovent Biologics, Inc., for an aggregate consideration of…

Davis Polk advised the representatives of the underwriters in an SEC-registered offering by Fifth Third Bancorp of 350,000 depositary shares, each representing a 1/25th ownership…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering by Lennox International Inc. of $300…

Davis Polk is advising Clarivate Plc on its approximately $6.8 billion combination with CPA Global. In the all-stock transaction, CPA Global shareholders will receive approximately 218…

Davis Polk advised Banco Votorantim S.A. in connection with the update of its global medium-term note program and offering thereunder of $500 million aggregate principal amount of 4.375%…

Davis Polk advised Freeport-McMoRan Inc. (“FCX”) in connection with its SEC-registered offering of $1.5 billion of senior notes. The offering consisted of $650 million of 4.375% senior…

Davis Polk advised the dealer manager in connection with BRF S.A.’s offer to purchase for cash any and all of its 5.875% senior notes due 2022, 2.750% senior notes due 2022, 3.950%…